These findings link CaSR in adipocytes to novel mechanisms between metabolic disorders and cardiovascular inflammation, suggesting that modulating CaSR activity in adipose tissue may be a potential strategy to mitigate obesity-related atherosclerosis. The gene discussed is CASR; the disease is obesity due to melanocortin 4 receptor deficiency.